Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Steinman

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The American Journal of Otology|September 26, 1997
Use of organotypic cultures of Corti's organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hair cellsR D Kopke, W Liu, R Gabaizadeh, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitorsD H Steinman, M L Curtin, R B Garland, et al.
Journal of Enzyme Inhibition|October 28, 1999
Evaluation of the inhibition of other metalloproteinases by matrix metalloproteinase inhibitorsP A Marcotte, I N Elmore, Z Guan, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2004
Isoindolinone ureas: a novel class of KDR kinase inhibitorsMichael L Curtin, Robin R Frey, H Robin Heyman, et al.
Journal of Medicinal Chemistry|January 5, 2002
Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitorsCarol K Wada, James H Holms, Michael L Curtin, et al.
Journal of Medicinal Chemistry|January 23, 1998
Discovery and evaluation of a series of 3-acylindole imidazopyridine platelet-activating factor antagonistsM L Curtin, S K Davidsen, H R Heyman, et al.
Bioorganic & Medicinal Chemistry Letters|June 20, 2001
Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770M L Curtin, A S Florjancic, H R Heyman, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The American Journal of Otology|September 26, 1997
Use of organotypic cultures of Corti's organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hair cellsR D Kopke, W Liu, R Gabaizadeh, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitorsD H Steinman, M L Curtin, R B Garland, et al.
Journal of Enzyme Inhibition|October 28, 1999
Evaluation of the inhibition of other metalloproteinases by matrix metalloproteinase inhibitorsP A Marcotte, I N Elmore, Z Guan, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2004
Isoindolinone ureas: a novel class of KDR kinase inhibitorsMichael L Curtin, Robin R Frey, H Robin Heyman, et al.
Journal of Medicinal Chemistry|January 5, 2002
Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitorsCarol K Wada, James H Holms, Michael L Curtin, et al.
Journal of Medicinal Chemistry|January 23, 1998
Discovery and evaluation of a series of 3-acylindole imidazopyridine platelet-activating factor antagonistsM L Curtin, S K Davidsen, H R Heyman, et al.
Bioorganic & Medicinal Chemistry Letters|June 20, 2001
Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770M L Curtin, A S Florjancic, H R Heyman, et al.
Pageof 2